Kohinoor Foods Limited (KOHINOOR.BO)
INR 40.67
(-1.93%)
INR 40.67
(-1.93%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 951 Million | 820.98 Million | 977.07 Million | 2.65 Billion | 2.15 Billion | 5.97 Billion |
| Cost of Revenue | 481.2 Million | 530.51 Million | 785.62 Million | 2 Billion | 1.71 Billion | 6.87 Billion |
| Gross Profit | 469.8 Million | 290.47 Million | 191.45 Million | 653.71 Million | 439.05 Million | -904.11 Million |
| Operating Expenses | 385.7 Million | 215.31 Million | 257.13 Million | 372.49 Million | 2.13 Billion | 657.3 Million |
| Selling, General and Administrative Expenses | 385.7 Million | 79.77 Million | 110.44 Million | 72.6 Million | 157.1 Million | 187.63 Million |
| Research and Development Expenses | - | 874 Thousand | 959 Thousand | 1.49 Million | 1.98 Million | 1.42 Million |
| Other Expenses | - | 11.85 Million | 5.6 Million | 16.29 Million | 322 Thousand | 11 Million |
| Cost and Expenses | 866.9 Million | 745.82 Million | 1.04 Billion | 2.37 Billion | 3.84 Billion | 7.53 Billion |
| Operating Income | 84.1 Million | 70.53 Million | -67.87 Million | 267.39 Million | -1.69 Billion | -2.41 Billion |
| Interest Expense | 179.2 Million | 178.26 Million | 3.7 Million | 40.62 Million | 27.72 Million | 233.43 Million |
| Income Tax Expense | -44.14 Million | -7.25 Million | 7.98 Million | 4.81 Million | 69.15 Million | 1.05 Billion |
| Earnings before Tax | -89.6 Million | -48.61 Million | -55.2 Million | 247.11 Million | -1.76 Billion | -3.12 Billion |
| Net Income | -45.5 Million | -41.36 Million | -63.18 Million | 242.29 Million | -1.83 Billion | -4.17 Billion |
| Earnings Per Share Basic | -1.27 | -1.12 | -1.70 | 6.54 | -49.55 | -115.50 |
| Earnings Per Share Diluted | -1.27 | -1.12 | -1.70 | 6.54 | -49.55 | -115.50 |
| Weighted Average Shares Outstanding | 35.82 Million | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million | 36.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.82 Million | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million | 36.13 Million |
| Gross Margin | 0.49 | 0.35 | 0.20 | 0.25 | 0.20 | -0.15 |
| EBIT Margin | 0.16 | 0.16 | 0.00 | 0.15 | -0.75 | -0.25 |
| Profit Margin | -0.05 | -0.05 | -0.06 | 0.09 | -0.85 | -0.70 |
| EBITDA | 152.64 Million | 198.45 Million | 28.8 Million | 396.03 Million | -1.57 Billion | -2.7 Billion |
| Earnings Before Tax Margin | 0.09 | 0.09 | -0.07 | 0.10 | -0.79 | -0.40 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 238.5 Million | 241.8 Million | 951 Million | 232.7 Million | 220.3 Million | 256.2 Million |
| Cost of Revenue | 110.8 Million | 120.3 Million | 481.2 Million | 116.9 Million | 80.8 Million | 101.1 Million |
| Gross Profit | 127.7 Million | 121.5 Million | 469.8 Million | 115.8 Million | 139.5 Million | 155.1 Million |
| Operating Expenses | 110.2 Million | 120.9 Million | 385.7 Million | 74.8 Million | 130.9 Million | 121.3 Million |
| Selling, General and Administrative Expenses | 110.2 Million | 120.9 Million | - | 74.8 Million | 98.4 Million | 91.6 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.4 Million | 6.27 Million | 6.3 Million | - | 18 Thousand | - |
| Cost and Expenses | 221 Million | 241.2 Million | 866.9 Million | 191.7 Million | 211.7 Million | 222.4 Million |
| Operating Income | 17.5 Million | 600 Thousand | 84.1 Million | 41 Million | 8.6 Million | 33.8 Million |
| Interest Expense | 43.7 Million | 45.6 Million | 179.2 Million | 44.9 Million | 44.5 Million | 44.2 Million |
| Income Tax Expense | - | -44.1 Million | -44.1 Million | 16.63 Million | 18 Thousand | 14.45 Million |
| Earnings before Tax | -25 Million | -38.6 Million | -89.7 Million | -4.6 Million | -36 Million | -10.4 Million |
| Net Income | -25 Million | 5.5 Million | -45.5 Million | -4.6 Million | -36 Million | -10.4 Million |
| Earnings Per Share Basic | -0.67 | 0.11 | - | -0.12 | -0.97 | -0.28 |
| Earnings Per Share Diluted | -0.67 | 0.11 | - | -0.12 | -0.97 | -0.28 |
| Weighted Average Shares Outstanding | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million | 37.07 Million |
| Gross Margin | 0.54 | 0.50 | 0.49 | 0.50 | 0.63 | 0.61 |
| EBIT Margin | 0.14 | 0.07 | - | 0.25 | 0.11 | 0.19 |
| Profit Margin | -0.10 | 0.02 | -0.05 | -0.02 | -0.16 | -0.04 |
| EBITDA | 32.2 Million | 17.6 Million | - | 57.6 Million | 23.5 Million | 48.3 Million |
| Earnings Before Tax Margin | 0.07 | 0.00 | 0.09 | 0.18 | 0.04 | 0.13 |
KLINIQ
300031
301190
TIIL
PCSA
0SAY